Exhaustive criteria and definitive data to identify the ideal lung oligometastatic patient as a
candidate for stereotactic body radiotherapy (SBRT) are lacking. Three distinct cohorts of …

Simple Summary Stereotactic body radiation therapy (SBRT) is currently used to treat lung
metastasis, particularly in the setting of oligometastatic disease. Objective of this treatment is …

To analyze the impact of SBRT on systemic treatment-free survival in patients affected by
lung oligometastases. Inclusion criteria of the study were (a) KPS> 70,(b) 1–5 lung …

Purpose The oligometastatic stage is an intermediate stage of cancer between the localized
stage and polymetastatic stage. The prognosis of patients in this stage also appears to be …

Purpose To assess the clinical results in terms of local control, toxicity, failure pattern and
toxicity of SBRT in oligometastatic patients with inoperable lung metastases. Methods Forty …

Background Stereotactic body radiotherapy (SBRT) for oligometastatic disease is
characterized by an excellent safety profile; however, experiences are mostly based on …

Purpose We report the retrospective data of a cohort of patients who received stereotactic
body radiotherapy for pulmonary oligometastases, aiming to assess the clinical factors …

Aim: This study was performed to confirm the superior overall survival (OS) after pulmonary
oligo-recurrence compared to pulmonary sync-oligometastases in a large nationwide study …

Background Oligometastases can be divided into sync-oligometastases and oligo-
recurrence. The difference is whether the primary site is uncontrolled or controlled. The goal …

Aim: The current study investigated outcomes and prognostic factors of pulmonary
oligometastases at two Institutions. Patients and Methods: SBRT (stereotactic body …